Gary S. Roubin - Nov 17, 2021 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Role: Director
Signature: /s/ Craig Shore, Attorney-in-Fact for Gary S. Roubin
Stock symbol: NSPR
Transactions as of: Nov 17, 2021
Transactions value $: $99,961
Form type: 4
Date filed: 11/18/2021, 03:05 PM
Previous filing: Oct 14, 2021
Next filing: Dec 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NSPR	Common Stock	Purchase	$98.9K	+25.6K	+29.69%	$3.86	112K	Nov 17, 2021	Direct	F1
transaction	NSPR	Common Stock	Purchase	$1.09K	+290	+0.26%	$3.77	112K	Nov 17, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NSPR	Warrants						22.9K	Nov 17, 2021	Common Stock			Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.77, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.77, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.